Tumor-targeted photodynamic therapy

Anticancer Research

Volumn 33, Issue 7, 2013, Pages 2823-2832

  Shirasu, Naoto ^a   Nam, Sung Ouk ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Drug delivery; Photodynamic therapy; Photosensitizer; Review; Tumor targeting

Indexed keywords

GOLD NANOPARTICLE; NANOMATERIAL;

CANCER THERAPY; CONFERENCE PAPER; HUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; TUMOR CELL; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT;

DRUG DELIVERY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZER; REVIEW; TUMOR TARGETING;

ANIMALS; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84883309884     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Plaetzer K, Krammer B, Berlanda J, Berr F and Kiesslich T: Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 24: 259-268, 2009.
2. Moan J: On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol B 6: 343-344, 1990.
3. Mroz P, Yaroslavsky A, Kharkwal GB and Hamblin MR: Cell death pathways in photodynamic therapy of cancer. Cancers 3: 2516-2539, 2011.
4. Yoo JO and Ha KS: New insights into the mechanisms for photodynamic therapy-induced cancer cell death. Int Rev Cell Mol Biol 295: 139-174, 2012.
5. Nanashima A, Abo T, Nonaka T, Nonaka Y, Morisaki T, Uehara R, Ohnita K, Fukuda D, Murakami G, Tou K, Kunizaki M, Hidaka S, Tsuchiya T, Takeshita H, Nakao K and Nagayasu T: Photodynamic therapy using talaporfin sodium [Laserphyrin(R)] for bile duct carcinoma: A preliminary clinical trial. Anticancer Res 32: 4931-4938, 2012.
6. Shibaguchi H, Tsuru H, Kuroki M and Kuroki M: Sonodynamic cancer therapy: A non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res 31: 2425-2429, 2011.
7. Verhille M, Couleaud P, Vanderesse R, Brault D, Barberi-Heyob M and Frochot C: Modulation of photosensitization processes for an improved targeted photodynamic therapy. Curr Med Chem 17: 3925-3943, 2010.
8. Lovell JF and Zheng G: Activatable smart probes for molecular optical imaging and therapy. J Innov Opt Health Sci 1: 45-61, 2008.
9. Minchinton AI and Tannock IF: Drug penetration in solid tumours. Nat Rev Cancer 6: 583-592, 2006.
10. Fang J, Nakamura H and Maeda H: The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63: 136-151, 2011.
11. Greish K: Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 624: 25-37, 2010.
12. El-Far MA and Pimstone NR: The interaction of tumourlocalizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen. Cell Biochem Funct 3: 115-119, 1985.
13. Vaupel P: Oxygen transport to tumors: Pathophysiology and clinical implications. In: The Primo Vascular System. Soh K, Kang KA and Harrison DK (eds.) Springer, New York, pp. 207-212, 2012.
14. Witkiewicz H, Oh P and Schnitzer JE: III. Cellular ultrastructures in situ as key to understanding tumor energy metabolism: biological significance of the Warburg effect. F1000Research 2: 10 (doi: 10.12688/f1000research.2-10.v1), 2013.
15. Tanaka M, Kataoka H, Mabuchi M, Sakuma S, Takahashi S, Tujii R, Akashi H, Ohi H, Yano S, Morita A and Joh T: Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer. Anticancer Res 31: 763-769, 2011.
16. Maeda H: Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects. Bioconjug Chem 21: 797-802, 2010.
17. Sutoris K, Vetvicka D, Horak L, Benes J, Nekvasil M, Jezek P, Zadinova M and Pouckova P: Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine. Anticancer Res 32: 3769-3774, 2012.
18. Molinari A, Bombelli C, Mannino S, Stringaro A, Toccacieli L, Calcabrini A, Colone M, Mangiola A, Maira G, Luciani P, Mancini G and Arancia G: m-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy. Int J Cancer 121: 1149-1155, 2007.
19. Bombelli C, Caracciolo G, Di Profio P, Diociaiuti M, Luciani P, Mancini G, Mazzuca C, Marra M, Molinari A, Monti D, Toccacieli L and Venanzi M: Inclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: Correlation between physicochemical and biological features of the complexes. J Med Chem 48: 4882-4891, 2005.
20. Pierre MB, Tedesco AC, Marchetti JM and Bentley MV: Stratum corneum lipids liposomes for the topical delivery of 5- aminolevulinic acid in photodynamic therapy of skin cancer: Preparation and in vitro permeation study. BMC Dermatol 1: 5, 2001.
21. Venosa GD, Hermida L, Fukuda H, Defain MV, Rodriguez L, Mamone L, MacRobert A, Casas A and Batlle A: Comparation of liposomal formulations of ALA undecanoyl ester for its use in photodynamic therapy. J Photochem Photobiol B 96: 152-158, 2009.
22. Salmaso S and Caliceti P: Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv: (doi:10.1155/2013/374252), 2013.
23. Anderson JM and Shive MS: Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 64(Suppl): 72-82, 2012.
24. Konan YN, Berton M, Gurny R and Allémann E: Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci 18: 241-249, 2003.
25. Konan YN, Cerny R, Favet J, Berton M, Gurny R and Allémann E: Preparation and characterization of sterile sub-200 nm mesotetra( 4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm 55: 115-124, 2003.
26. Ding H, Mora R, Gao J and Sumer BD: Characterization and optimization of mTHPP nanoparticles for photodynamic therapy of head and neck cancer. Otolaryngol Head Neck Surg 145: 612-617, 2011.
27. Prabaharan M: Chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 23: 5-36, 2008.
28. Lee SJ, Koo H, Lee D, Min S, Lee S, Chen X, Choi Y, Leary JF, Park K, Jeong SY, Kwon IC, Kim K and Choi K: Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 32: 4021-4029, 2011.
29. Lim CK, Shin J, Kwon IC, Jeong SY, and Kim S: Iodinated photosensitizing chitosan: Self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation. Bioconjug Chem 2012.
30. Solov'ev KN and Borisevich EA: Intramolecular heavy-atom effect in the photophysics of organic molecules. Physics Uspekhi 48: 231, 2005.
31. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F and Barberi-Heyob M: Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 26: 612-621, 2008.
32. Tang W, Xu H, Park EJ, Philbert MA and Kopelman R: Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem Biophys Res Commun 369: 579-583, 2008.
33. Gao D, Agayan RR, Xu H, Philbert MA and Kopelman R: Nanoparticles for two-photon photodynamic therapy in living cells. Nano letters 6: 2383-2386, 2006.
34. Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF and El-Sayed MA: Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269: 57-66, 2008.
35. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ and Prasad PN: Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125: 7860-7865, 2003.
36. Zhao B, Yin JJ, Bilski PJ, Chignell CF, Roberts JE and He YY: Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol Appl Pharmacol 241: 163-172, 2009.
37. Simon V, Devaux C, Darmon A, Donnet T, Thiénot E, Germain M, Honnorat J, Duval A, Pottier A, Borghi E, Levy L and Marill J: PpIX silica nanoparticles demonstrate differential interactions with in vitro tumor cell lines and in vivo mouse models of human cancers. Photochem Photobiol 86: 213-222, 2010.
38. Tong L, Wei Q, Wei A and Cheng JX: Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol 85: 21-32, 2009.
39. Wang S, Gao R, Zhou F and Selke M: Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J Mater Chem 14: 487-493, 2004.
40. Cheng Y, Meyers JD, Broome AM, Kenney ME, Basilion JP and Burda C: Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc 133: 2583-2591, 2011.
41. Zhang Z, Wang J and Chen C: Gold nanorods based platforms for light-mediated theranostics. Theranostics 3: 223-238, 2013.
42. Jang B and Choi Y: Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics 2: 190-197, 2012.
43. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R and Langer R: Nanocarriers as an emerging platform for cancer therapy. Nat Nano 2: 751-760, 2007.
44. Wu AM and Senter PD: Arming antibodies: Prospects and challenges for immunoconjugates. Nat Biotechnol 23: 1137-1146, 2005.
45. Savellano MD and Hasan T: Photochemical targeting of epidermal growth factor receptor: A mechanistic study. Clin Cancer Res 11: 1658-1668, 2005.
46. Savellano MD, Pogue BW, Hoopes PJ, Vitetta ES and Paulsen KD: Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res 65: 6371-6379, 2005.
47. Kuimova MK, Bhatti M, Deonarain M, Yahioglu G, Levitt JA, Stamati I, Suhling K and Phillips D: Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fvphotosensitizer conjugates suitable for photodynamic therapy. Photochem Photobiol Sci 6: 933-939, 2007.
48. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL and Kobayashi H: Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 17: 1685-1691, 2011.
49. Shirasu N, Yamada H, Shibaguchi H, Kuroki M, and Kuroki M: Tumor-selective near-infrared-photoimmunotherapy using a human anti-CEA monoclonal antibody. Mol Tumor Marker Res 28: in press, 2013.
50. Kuo WS, Chang CN, Chang YT, Yang MH, Chien YH, Chen SJ and Yeh CS: Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angewandte Chemie 122: 2771-2775, 2010.
51. Lutsenko SV, Feldman NB, Finakova GV, Posypanova GA, Severin SE, Skryabin KG, Kirpichnikov MP, Lukyanets EA and Vorozhtsov GN: Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates. Tumour Biol 20: 218-224, 1999.
52. Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F and Soula G: Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie 75: 811-819, 1993.
53. Mazière JC, Morlière P and Santus R: The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J Photochem Photobiol B 8: 351-360, 1991.
54. Song L, Li H, Sunar U, Chen J, Corbin I, Yodh A and Zheng G: Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. Int J Nanomed 2: 767-774, 2007.
55. Schmidt-Erfurth U, Diddens H, Birngruber R and Hasan T: Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 75: 54-61, 1997.
56. Urizzi P, Allen CM, Langlois R, Ouellet R, LA Madeleine C and van Lier JE: Low-density lipoprotein-bound aluminum sulfophthalocyanine: Targeting tumor cells for photodynamic therapy. J Porphyrins Phthalocyanines 5: 154-160, 2001.
57. Obochi MO, Boyle RW and van Lier JE: Biological activities of phthalocyanines. XIII. The effects of human serum components on the in vitro uptake and photodynamic activity of zinc phthalocyanine. Photochem Photobiol 57: 634-640, 1993.
58. Stevens PJ, Sekido M and Lee RJ: Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation. Anticancer Res 24: 161-166, 2004.
59. Syu W, Yu H, Hsu C, Rajan Y, Hsu Y, Chang Y, Hsieh W, Wang C and Lai P: Improved photodynamic cancer treatment by folateconjugated polymeric micelles in a KB xenografted animal model. Small 8: 2060-2069, 2012.
60. Sibrian-Vazquez M, Jensen TJ and Vicente MG: Porphyrin- retinamides: Synthesis and cellular studies. Bioconjug Chem 18: 1185-1193, 2007.
61. Khan EH, Ali H, Tian H, Rousseau J, Tessier G, Shafiullah and van Lier JE: Synthesis and biological activities of phthalocyanine- estradiol conjugates. Bioorg Med Chem Lett 13: 1287-1290, 2003.
62. Swamy N, James DA, Mohr SC, Hanson RN and Ray R: An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg Med Chem 10: 3237-3243, 2002.